Abstract
Alimentary Pharmacology & TherapeuticsVolume 9, Issue 1 p. 85-86 Free Access Letters to the Editors W. A. de Boer, W. A. de Boer Saint Joseph Hospital Department of Internal Medicine Veldhoven, The NetherlandsSearch for more papers by this authorJ. G. Penston, J. G. Penston Medical Consultant to Glaxo Pharmaceuticals UK Ltd Dundee, UKSearch for more papers by this author W. A. de Boer, W. A. de Boer Saint Joseph Hospital Department of Internal Medicine Veldhoven, The NetherlandsSearch for more papers by this authorJ. G. Penston, J. G. Penston Medical Consultant to Glaxo Pharmaceuticals UK Ltd Dundee, UKSearch for more papers by this author First published: February 1995 https://doi.org/10.1111/j.1365-2036.1995.tb00357.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Penston J G, Review article: Helicobacter pylori eradication—understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994; 8: 369– 89. 2 National Institute of Health Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65– 9. 3 Wilhelmsen I, Berstad A. Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori. Scand J Gastroenterol 1994; 29: 874– 9. 4 Labenz J, Borsch G. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol 1994; 89: 1785– 8. 5 Borody T J, Andrews P, Manusco N, et al. Helicobacter pylori reinfection rate in patients with cured duodenal ulcer. Am J Gastroenterol 1994; 89: 529– 32. 6 de Boer W A, Driessen W M M, Potters H V P J, Tytgat G N J. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994; 89 (November). (in press). 7 de Boer W A, Driessen W M M, Jansz A R, Tytgat G N J. Concomitant acid suppression increases the efficacy of traditional anti-Helicobacter pylori triple therapy. Results of a randomised prospective study of triple therapy with or without omeprazole. Presented at the scientific meeting of the Dutch society of Gastroenterology, Veldhoven, October 1994 (Abstract). REFERENCES 1 Penston J G. Review article: Helicobacter pylori eradication—understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994; 8: 369– 89. 2 National Institute of Health Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65– 9. Volume9, Issue1February 1995Pages 85-86 ReferencesRelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
